1999
Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody‐associated congenital heart block: Retrospective review of the research registry for neonatal lupus
Saleeb S, Copel J, Friedman D, Buyon J. Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody‐associated congenital heart block: Retrospective review of the research registry for neonatal lupus. Arthritis & Rheumatism 1999, 42: 2335-2345. PMID: 10555029, DOI: 10.1002/1529-0131(199911)42:11<2335::aid-anr12>3.0.co;2-3.Peer-Reviewed Original ResearchConceptsCongenital heart blockSecond-degree blockThird-degree blockGroup B fetusesGroup BGroup AHeart blockAge 4 yearsNeonatal lupusPericardial effusionPleural effusionResearch RegistryFluorinated steroidsAutoantibody-associated congenital heart blockAnti-SSB/La antibodiesAnti-SSA/RoFluorinated glucocorticoidsNatural historyInitial echocardiographic evaluationDuration of pregnancyIntrauterine growth restrictionFirst-degree blockNumber of deathsComparison of treatmentsSteroid therapy
1997
Does a prenatal diagnosis of congenital heart disease alter short‐term outcome?
Copel J, Tan A, Kleinman C. Does a prenatal diagnosis of congenital heart disease alter short‐term outcome? Ultrasound In Obstetrics And Gynecology 1997, 10: 237-241. PMID: 9383873, DOI: 10.1046/j.1469-0705.1997.10040237.x.Peer-Reviewed Original ResearchConceptsCongenital heart diseaseLength of hospitalizationPrenatal diagnosis groupInitial hospitalizationDiagnosis groupsGroup IBiventricular repairHeart diseaseOutcome measuresGroup IIPrenatal diagnosisLong-term mortality riskYale-New Haven HospitalDuctal-dependent lesionsFatal congenital anomalyStudy entry criteriaSingle ventricle physiologyPrimary outcome measureShort-term outcomesCost of hospitalizationLife-threatening conditionHospital dischargePrimary admissionVentricle physiologyAntenatal cases